Cytokinetics | CYTK - أصول متداولة





أصول متداولة تغيير تاريخ
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Amgen USD 34.36B 598M 2026-09
Arca Biopharma USD 941.49M 56.93M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Biogen USD 7.58B 278.7M 2026-09
Brainstorm Cell Therapeutics USD 316K 132K 2026-06
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Capricor Therapeutics USD 202.25M 39.88M 2026-09
Cytokinetics USD 1.19B 21.34M 2026-09
Eisai JPY 866.82B 16.2B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Exelixis USD 1.32B 70.8M 2026-09
Geron USD 468.74M 17.6M 2026-09
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
Merck USD 38.94B 2.26B 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09